We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$427M
AUM Growth
+$4.69M
Cap. Flow
+$1.94M
Cap. Flow %
0.45%
Top 10 Hldgs %
56.98%
Holding
37
New
6
Increased
10
Reduced
14
Closed
4

Top Buys

Rank Stock Value
1
SYK icon
Stryker
SYK
+$17.3M
2
WCG
Wellcare Health Plans, Inc.
WCG
+$11.5M
3
BMY icon
Bristol-Myers Squibb
BMY
+$10.3M
4
VOLC
VOLCANO CORPORATION COM STK
VOLC
+$7.72M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.09M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$12.9M
2
A icon
Agilent Technologies
A
+$9.6M
3
LLY icon
Eli Lilly
LLY
+$9.24M
4
RDY icon
Dr. Reddy's Laboratories
RDY
+$6.31M
5
ACOR
Acorda Therapeutics
ACOR
+$6.19M

Sector Composition

Rank Sector Weight
1 Healthcare 85.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IART icon
26
Integra LifeSciences
IART
$1.54B
$5.67M 1.33%
279,365
+22,241
+9% +$443K
CTRX
27
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
$4.78M 1.12%
113,500
– –
CI icon
28
Cigna
CI
$76.6B
$4.44M 1.04%
49,000
+9,000
+23% +$841K
AGN
29
DELISTED
Allergan Inc
AGN
$3.56M 0.83%
+20,000
New +$3.32M
MDCO
30
DELISTED
Medicines Co
MDCO
$3.47M 0.81%
155,450
-28,800
-16% -$731K
AVNR
31
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$2.73M 0.64%
229,400
-440,000
-66% -$3M
AUXL
32
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$2.56M 0.6%
85,920
-88,200
-51% -$1.87M
SPPI
33
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$566K 0.13%
69,500
+19,500
+39% +$153K
A icon
34
Agilent Technologies
A
$39.1B
– –
-233,746
Closed -$9.6M
ABBV icon
35
AbbVie
ABBV
$458B
– –
-228,500
Closed -$12.9M
RDY icon
36
Dr. Reddy's Laboratories
RDY
$9.82B
– –
-730,760
Closed -$6.31M
UNH icon
37
UnitedHealth
UNH
$382B
– –
-27,000
Closed -$2.21M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q3 2014 Portfolio in Review

As of Q3 2014, Sector Gamma AS held 37 positions worth $427M, up 1.1% from $423M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Sector Gamma AS's Q3 2014 filing shows 6 new, 10 increased, 14 reduced and 4 closed positions. Its largest new stake was Stryker: 210,183 shares worth $17M. The largest sale was AbbVie, an estimated $12.9M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 88% a quarter earlier.

  • Sector Gamma AS's largest Q3 2014 buy was Stryker: 210,183 shares worth $17M.
  • Sector Gamma AS added most to Bristol-Myers Squibb in Q3 2014, an estimated $10.3M increase.
  • Sector Gamma AS's biggest Q3 2014 reduction was Eli Lilly, cutting an estimated $9.24M.
  • Sector Gamma AS fully exited AbbVie in Q3 2014, selling an estimated $12.9M.
  • Sector Gamma AS's ten largest holdings make up 57% of its $427M portfolio in Q3 2014.
  • Sector Gamma AS opened 6 new positions and closed 4 in Q3 2014.
  • Sector Gamma AS's portfolio value rose 1.1% quarter-over-quarter to $427M.

Based on Sector Gamma AS's 13F filing for Q3 2014, filed 13 Nov 2014.